BREAKING
IMUNON 2025 Financial Review 2 minutes ago BIO-key International, Inc. (BKYI) Reports Q4 Earnings 51 minutes ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 54 minutes ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 1 hour ago TON Strategy Company (VERB) Reports FY2025 Earnings 2 hours ago Allarity Therapeutics, Inc. (ALLR) Reports FY2025 Earnings 2 hours ago McCormick & Company, Incorporated (MKC) Q1 2026 Earnings Recap 2 hours ago J.Jill, Inc. (JILL) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago OS Therapies Incorporated (OSTX) Reports FY2025 Earnings 2 hours ago Palvella Therapeutics, Inc. (PVLA) Reports FY2025 Earnings 2 hours ago IMUNON 2025 Financial Review 2 minutes ago BIO-key International, Inc. (BKYI) Reports Q4 Earnings 51 minutes ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 54 minutes ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 1 hour ago TON Strategy Company (VERB) Reports FY2025 Earnings 2 hours ago Allarity Therapeutics, Inc. (ALLR) Reports FY2025 Earnings 2 hours ago McCormick & Company, Incorporated (MKC) Q1 2026 Earnings Recap 2 hours ago J.Jill, Inc. (JILL) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago OS Therapies Incorporated (OSTX) Reports FY2025 Earnings 2 hours ago Palvella Therapeutics, Inc. (PVLA) Reports FY2025 Earnings 2 hours ago
ADVERTISEMENT
Breaking News

LivePerson (LPSN) Q4 Loss Narrows to $4.14/Share; Revenue Drops 19% to $59.3M

LivePerson's Q4 loss widened to $3.92/share as revenue fell 19% YoY to $59.3M; Q1 guidance of $63-65M signals potential stabilization.

March 13, 2026 2 min read
salesforce

LivePerson's Q4 loss widened to $3.92/share as revenue fell 19% YoY to $59.3M; Q1 guidance of $63-65M signals potential stabilization.

Loss Per Share (GAAP)
$4.14
Revenue
$59.3M

Loss Narrows. LivePerson reported a loss of $4.14 per share for Q4 2025, narrowing sharply from the year-ago loss of $0.19 per share. The software provider’s loss narrowed sharply year-over-year.

Revenue slides 19%. Q4 revenue of $59.3 million fell 19.0% from $73.2 million in the year-ago quarter. The company reported a net loss of $46.1 million for the quarter. Adjusted EBITDA rose to $10.8 million, indicating some operational leverage.

Q1 guidance signals stabilization. Management issued Q1 2026 revenue guidance of $53 million to $55 million, representing a potential sequential uptick at the midpoint. The stock traded at $2.85, near its 52-week low of $2.56, with volume of 264,423 shares.

What to Watch: Q1 2026 results will test whether the guidance marks a genuine revenue inflection or merely a temporary bounce—execution against that range is the only metric that matters for a stock trading at multi-year lows.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT
Tags: #LPSN